Einträge von Falk, W auf dem Publikationsserver

Hausmann, M, Paul, G, Kellermeier, S, Frey, I, Schölmerich, J, Falk, W, Menzel, K, Fried, M, Herfarth, H und Rogler, G (2008) (GT)n Dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease course. Clinical and Experimental Immunology 153 (1), S. 81-85. Volltext nicht vorhanden.

Straub, R H , Grum, F, Strauch, U, Capellino, S , Bataille, F, Bleich, A, Falk, W, Scholmerich, J und Obermeier, F (2008) Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut 57 (7), S. 911-921. Volltext nicht vorhanden.

Blaas, S H, Stieber-Gunckel, M, Falk, W, Obermeier, F und Rogler, G (2008) CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clinical and Experimental Immunology 155 (3), S. 534-540. Volltext nicht vorhanden.

Hausmann, M, Paul, G, Menzel, K, Brunner-Ploss, R, Falk, W, Schölmerich, J, Herfarth, H und Rogler, G (2008) NAT1 Genotypes Do not Predict Response to Mesalamine in Patients with Ulcerative Colitis. Zeitschrift für Gastroenterologie 46 (3), S. 259-265. Volltext nicht vorhanden.

Lippert, E, Gunckel, M, Brenmoehl, J, Bataille, F, Falk, W, Scholmerich, J, Obermeier, F und Rogler, G (2008) Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation. Clinical and Experimental Immunology 152 (2), S. 285-297. Volltext nicht vorhanden.

Hausmann, M, Obermeier, F, Paper, D H, Balan, K, Dunger, N, Menzel, K, Falk, W, Schoelmerich, J, Herfarth, H und Rogler, G (2007) In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis. Clinical and Experimental Immunology 148 (2), S. 373-381. Volltext nicht vorhanden.

Menzel, K, Hausmann, M, Obermeier, F, Schreiter, K, Dunger, N, Bataille, F, Falk, W, Scholmerich, J, Herfarth, H und Rogler, G (2006) Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clinical and Experimental Immunology 146 (1), S. 169-180. Volltext nicht vorhanden.

Spoettl, T, Hausmann, M, Herlyn, M, Gunckel, M, Dirmeier, A, Falk, W, Herfarth, H, Schoelmerich, J und Rogler, G (2006) Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes. Clinical and Experimental Immunology 145 (1), S. 190-199. Volltext nicht vorhanden.

Stopfer, P, Obermeier, F, Dunger, N, Falk, W, Farkas, S, Janotta, M, Möller, A, Männel, D N und Hehlgans, T (2004) Blocking lymphotoxin-βreceptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. Clinical and Experimental Immunology 136 (1), S. 21-29. Volltext nicht vorhanden.

Straub, RH, Lehle, K, Herfarth, H, Weber, M, Falk, W, Preuner, J und Scholmerich, J (2002) Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. European Journal of Endocrinology, S. 365-374. Volltext nicht vorhanden.

Herfarth, H, Brand, K, Rath, H C, Rogler, G , Schölmerich, J und Falk, W (2001) Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clinical and Experimental Immunology 120 (1), S. 59-65. Volltext nicht vorhanden.

Martin-Villalba, A , Hahne, M, Kleber, S, Vogel, J, Falk, W, Schenkel, J und Krammer, P H (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death & Differentiation 8 (7), S. 679-686. Volltext nicht vorhanden.